Log in or Sign up for Free to view tailored content for your specialty!
Thyroid News
Fracture rates similar between adults with Graves’ disease and general population
Adults with Graves’ disease do not have an increased risk for an osteoporosis-related fracture later in life compared with those without Graves’ disease, according to data from a retrospective study published in Thyroid.
Selpercatinib improves outcomes in RET-mutant medullary thyroid cancer
MADRID — Selpercatinib improved outcomes compared with cabozantinib or vandetanib for treatment of RET-mutant medullary thyroid cancer, according to randomized phase 3 study results presented at ESMO Congress.
Log in or Sign up for Free to view tailored content for your specialty!
Close association of diabetes and thyroid dysfunction has clinical implications
It is not uncommon for endocrinologists to treat adults with both diabetes and thyroid disease.
Secondary solid tumors common among those who developed thyroid cancer after Chernobyl
Men and women who developed thyroid cancer after the Chernobyl nuclear disaster had a significantly higher incidence of secondary solid tumors, according to study results published in JAMA Network Open.
Thyroid dysfunction in HCM predicts risk for sudden cardiac death, worsening HF
Adults with hypertrophic cardiomyopathy who had lower levels of free triiodothyronine were 53% more likely to experience sudden cardiac death and were at nearly fourfold greater risk for worsening HF, data show.
Elevated first-trimester TSH may increase risk for gestational diabetes
Women who have a higher thyroid-stimulating hormone level early in pregnancy may have an increased risk for developing gestational diabetes, according to findings published in The Journal of Clinical Endocrinology & Metabolism.
Lack of knowledge, distress are barriers to active surveillance for thyroid cancer
Adults with low-risk thyroid cancer cite concerns about adverse outcomes, psychological distress and a negative response to their diagnosis as reasons they opted for surgery over active surveillance, according to study findings.
Risk for thyroid eye disease rises within 4 weeks of COVID-19 vaccination
Adults may have an increased risk for new-onset or recurrent thyroid eye disease in the 28 days after receiving a COVID-19 vaccine dose, according to findings published in The Journal of Clinical Endocrinology & Metabolism.
Teprotumumab, tocilizumab improve thyroid eye disease symptoms within 24 weeks
Both teprotumumab and tocilizumab reduce inflammation and thyroid eye disease severity, including among adults who were nonresponders to steroid treatment, according to findings published in Thyroid.
Thyroid cancer surgeries at very low-volume centers increase odds for complications
Adults who undergo thyroid cancer surgery at clinics performing five or fewer operations per year are more likely to have recurrence or persistent disease than those attending higher-volume centers, according to study data.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read